Notice of Results and Investor Presentation
Sareum Holdings PLC will announce its unaudited interim results for the six months ended 31 December 2025 on Thursday, 12 March 2026, and will host an investor presentation on the same day at 14:00 GMT via the Investor Meet Company platform. The company, a clinical-stage biotechnology firm focused on kinase inhibitors for autoimmune disease and cancer, is providing this update to shareholders and potential investors.
Select text to share a quote on X · sign in to keep highlights & notes in your SAR notes
Cambridge, UK, 3 March 2026 - Sareum Holdings plc (AIM: SAR), a clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease and cancer, will announce its unaudited financial results for the six months ended 31 December 2025 on Thursday, 12 March 2026.
The Company will also be holding a live presentation to investors on Thursday, 12 March 2026 at 14:00 GMT via the Investor Meet Company platform.
Investors can sign up to Investor Meet Company for free and add to meet SAREUM HOLDINGS PLC via: https://www.investormeetcompany.com/sareum-holdings-plc/register-investor
Investors who already follow SAREUM HOLDINGS PLC on the Investor Meet Company platform will automatically be invited.
A copy of the presentation will be made available on the Company's website following the presentation.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.